Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers. - Wikidata - wikimedia - TriplyDB

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

http://www.wikidata.org/entity/Q46650423

about

Comparison of echinocandin antifungals Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.Micafungin in the treatment of invasive candidiasis and invasive aspergillosis Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction.The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.Micafungin: a new echinocandin antifungal.The echinocandins.The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.A comparative evaluation of properties and clinical efficacy of the echinocandins.Micafungin for the prophylaxis and treatment of Candida infections.Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics.Impact of special patient populations on the pharmacokinetics of echinocandins.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Caspofungin for the treatment of immunocompromised and severely ill children and neonates with invasive fungal infections Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization.Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats.Interactions between anti-infective agents and immunosuppressants in solid organ transplantation.Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.Pharmacokinetics of micafungin in HIV positive patients with confirmed esophageal candidiasis.Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.Clinical utility of micafungin: pharmacokinetics, dosing, use in special populations and drug interactions

P2860

Q28273738-692A3C31-C179-4EA7-AC6F-8C72FA1AF939 Q34045450-36E7F1DC-0C36-4105-9B4B-EE7916A6BCC5 Q34211108-22D6FD9B-E057-41D8-A8F1-901BD4F09475 Q35026516-CEC9C563-C4EF-42EC-8767-46B7C4DC4B8A Q35170424-0DD7C1D6-EA77-4EB2-8C63-0AEB01E99EB2 Q35860004-F6079E63-A534-40BF-8109-9ED19B7439F5 Q36004967-9592FE91-6CAB-4251-9C9A-E929EE36E063 Q36626518-0A62BB1B-3122-473B-9224-F03DE058DC6F Q36693843-6D43CA77-4250-44EA-B089-DF88DDFA37C1 Q36742397-87D4913A-2966-4391-A98B-1EBB54D1213E Q36828156-AACA0C3B-C8DF-46AC-A770-A983B47B09AA Q36895679-4F2E1D49-CD81-492A-9529-11F5EFC57006 Q36895839-E15510F3-65C8-4496-8233-CFA610E2C988 Q37124868-50385B11-15CD-4CD8-B396-8D6F4C6E6603 Q37904672-BAC30E74-B74B-470F-AF56-486BE880B2FF Q38462784-D1514E73-1737-4FA6-8D64-591C2E7CC392 Q38681635-2141E143-83BF-4A46-913B-14FF8281336A Q39701953-0D841D05-6AD6-48B6-924B-4175CCE730FB Q40100873-D7C99894-1128-407E-9FDA-14318DD1E34E Q40546653-2A2DAF5D-66E2-4554-86A3-2D06648447FA Q41929256-BC3B7C6B-8213-4E0B-B912-4219C4616707 Q42111914-D39ECE9D-8CC4-45E0-AFA6-AE0365493C10 Q42272268-4E009555-E423-486B-B115-9342A1DAE788 Q42612968-3013673B-9409-42D0-944B-4B5CF0F884F1 Q44685491-86C841C1-F2D5-4243-BA1F-1F72A71729FE Q47876785-C75CB9B1-0344-4810-9D75-B2A73BDCB21C Q48238550-C8C0A251-1F33-474D-9D18-D62B37DC6747 Q57518516-3F043189-D52B-4518-BF11-A32351A5B19F

P2860

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

http://www.wikidata.org/entity/Q46650423

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@en

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@nl

type

label

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@en

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@nl

prefLabel

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@en

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@nl

P1433

Q46650423-D8369E9A-9244-4007-BA69-034AE24FEF7D

P1476

Q46650423-9D5DF528-FDE6-4839-9CB6-0B93AA8EC807

P2093

Q46650423-27F4D96A-7450-4FB4-A660-7D12DD830629

Q46650423-2B32A016-17E1-4A3A-8089-2235E48EA21C

Q46650423-54DC3CA0-82C2-46C7-ADD4-6A9E24FAC29E

Q46650423-7564B983-843E-4C19-9DA6-706DED550E3C

Q46650423-A4C71A9F-4B14-405D-8788-F4FB2210AD60

Q46650423-AF446679-55C8-4327-A104-62729533F3AE

Q46650423-CC0C2FAA-7CAB-4128-8984-88AA9823F376

P2860

Q46650423-173EA745-70DD-4AC1-A95C-5548DFC453E5

Q46650423-2B5872EB-3543-4C5F-9338-501EBEE6A609

Q46650423-3512701A-BB1F-48E6-95C3-11C55368CE90

Q46650423-47EAC31C-3FE4-45F4-B680-DA29224380DC

Q46650423-647A9DFA-C50E-426D-BA8B-7E8A00ABCD2E

Q46650423-A041270A-753F-4001-B1B6-3CD2237CD424

Q46650423-A407E627-DA34-4F38-A45E-C16C3CBB2286

Q46650423-BEE0EAF2-016E-48AC-94DB-DE00D344EE36

P304

Q46650423-0F5026A4-8FE8-47AB-ADCB-A458AC7C6EBC

P31

Q46650423-D879E8E5-108A-4A42-91D8-361F8AFB6A8C

P356

Q46650423-DF8A291A-1FBC-4A0B-A512-262CE3134065

P433

Q46650423-573051A0-A57A-404D-AE76-1E9276E17584

P478

Q46650423-4EC178DD-FFD5-49AE-A9BB-47CE820D6496

P577

Q46650423-3B9A9E2B-9447-4D91-821A-65B3ED7C8F4A

P698

Q46650423-D60BCFF6-4DA4-4BA9-8C77-2ABF8187EF50

P356

0091270005279274

P1433

The Journal of Clinical Pharmacology

P1476

Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.

@en

P2093

David K Blough

http://www.w3.org/2001/XMLSchema#string

Donald Buell

http://www.w3.org/2001/XMLSchema#string

Ihor Bekersky

http://www.w3.org/2001/XMLSchema#string

James Keirns

http://www.w3.org/2001/XMLSchema#string

Mark Allison

http://www.w3.org/2001/XMLSchema#string

Mary F Hebert

http://www.w3.org/2001/XMLSchema#string

Robert W Townsend

http://www.w3.org/2001/XMLSchema#string

P2860

Noncompartmental determination of the steady-state volume of distribution.

Safety and tolerability of caspofungin acetate in the treatment of fungal infections.

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

In vitro metabolism of cyclosporine A by human kidney CYP3A5.

Analysis of the blood level of micafungin involving patients with hematological diseases: new findings regarding combination therapy with tacrolimus.

Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers.

CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects.

P304

1018-1024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270005279274

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16100295

http://www.w3.org/2001/XMLSchema#string